Present study demonstrates an additional role of COX-2-in human breast cancer: a stimulation of VEGF-C and thereby lymphangiogenesis in situ, also reported recently for non-small cell lung cancer cells (Su et al, 2004). This evidence concerns the gene VEGFC and breast carcinoma.